0,653  0,024  Antineoplastic (lung cancer)
0,612  0,022  Antineoplastic (colorectal cancer)
0,610  0,021  Antineoplastic (colon cancer)
0,540  0,046  Antineoplastic (breast cancer)
0,394  0,032  UGT2B4 substrate
0,372  0,041  UGT1A9 substrate
0,355  0,032  UGT1A6 substrate
0,384  0,066  Ulceration
0,309  0,009  Nitric-oxide synthase stimulant
0,402  0,110  Caspase 9 stimulant
0,338  0,046  NOS2 expression inhibitor
0,335  0,044  Antineoplastic (small cell lung cancer)
0,279  0,006  Toll-Like receptor 2 antagonist
0,318  0,047  Free radical scavenger
0,330  0,066  AR expression inhibitor
0,323  0,060  CTGF expression inhibitor
0,324  0,070  Vasodilator, coronary
0,316  0,064  Antineoplastic (melanoma)
0,274  0,027  Neurotrophic factor enhancer
0,282  0,043  5 Hydroxytryptamine 1E antagonist
0,296  0,063  Antioxidant
0,278  0,046  Tyrosine 3 hydroxylase inhibitor
0,251  0,021  LDLR expression enhancer
0,299  0,071  Antineoplastic (osteosarcoma)
0,298  0,081  Sodium/bile acid cotransporter inhibitor
0,289  0,073  5 Hydroxytryptamine release stimulant
0,313  0,098  CYP2C9 substrate
0,259  0,049  Antihypotensive
0,301  0,094  Transcription factor NF kappa B inhibitor
0,281  0,075  CYP2C19 substrate
0,279  0,085  NOS3 expression inhibitor
0,263  0,072  Antineoplastic (renal cancer)
0,259  0,072  5 Hydroxytryptamine uptake stimulant
0,324  0,137  Calcium channel L-type activator
0,218  0,035  Melanin inhibitor
0,264  0,083  Antiosteoporotic
0,207  0,029  Cocaine dependence treatment
0,264  0,088  Hypoxia-inducible factor 1 alpha inhibitor
0,249  0,073  Cardiovascular analeptic
0,230  0,055  UGT1A1 substrate
0,226  0,051  UGT2B7 substrate
0,190  0,020  Bronchodilator
0,204  0,034  UGT2B10 substrate
0,183  0,015  Papain-like protease (SARS coronavirus) inhibitor
0,216  0,049  Antimutagenic
0,255  0,092  Insulysin inhibitor
0,262  0,100  CYP2D6 substrate
0,184  0,023  Adenylate cyclase stimulant
0,318  0,160  Apoptosis agonist
0,201  0,042  UGT2B15 substrate
0,165  0,008  Antiprotozoal activity enhancer
0,204  0,049  UGT1A3 substrate
0,251  0,096  Cardioprotectant
0,204  0,051  VEGF expression inhibitor
0,198  0,047  Prostate disorders treatment
0,257  0,106  Caspase 3 stimulant
0,191  0,040  Tubulin antagonist
0,154  0,004  Estrogen-related receptor beta agonist
0,210  0,065  UDP-glucuronosyltransferase substrate
0,246  0,103  Respiratory analeptic
0,254  0,111  Bone diseases treatment
0,165  0,030  Endometrios treatment
0,183  0,048  Contraceptive
0,167  0,032  Alpha 2b adrenoreceptor antagonist
0,244  0,112  12-Lipoxygenase inhibitor
0,157  0,026  UGT2B1 substrate
0,205  0,075  Amyloid beta aggregation inhibitor
0,223  0,093  Aldehyde oxidase inhibitor
0,214  0,084  Cardiodepressant
0,157  0,029  Alpha 2c adrenoreceptor antagonist
0,157  0,032  Vanilloid 1 agonist
0,144  0,025  Prolactin inhibitor
0,145  0,028  Chronic obstructive bronchitis treatment
0,224  0,107  Antineoplastic (ovarian cancer)
0,161  0,044  Topoisomerase II inhibitor
0,276  0,160  Antiparkinsonian
0,188  0,072  Nitric oxide antagonist
0,167  0,054  Genotoxic
0,117  0,004  Melatonin agonist
0,157  0,046  DNA polymerase I inhibitor
0,207  0,101  Antihypercholesterolemic
0,241  0,139  CYP3A4 substrate
0,101  0,004  Melatonin 2 agonist
0,147  0,056  Skin whitener
0,187  0,099  Antialcoholic
0,251  0,163  TNF expression inhibitor
0,243  0,156  Calcium channel activator
0,135  0,048  Contraceptive female
0,127  0,041  Sulfotransferase substrate
0,142  0,055  Antihelmintic (Trematoda)
0,167  0,082  Antineoplastic (bone cancer)
0,142  0,056  M18 aspartyl aminopeptidase inhibitor
0,089  0,005  Melatonin antagonist
0,180  0,096  Antimitotic
0,101  0,016  Beta adrenoreceptor antagonist
0,127  0,043  Estrogen antagonist
0,161  0,078  Prostatic (benign) hyperplasia treatment
0,203  0,121  Proliferative diseases treatment
0,187  0,106  Antineoplastic (lymphoma)
0,157  0,077  Uterine stimulant
0,173  0,095  CYP2B6 inhibitor
0,222  0,148  ICAM1 expression inhibitor
0,126  0,052  Topoisomerase I inhibitor
0,148  0,075  NOS3 expression enhancer
0,086  0,014  Beta 1 adrenoreceptor antagonist
0,119  0,048  Electron transport complex I inhibitor
0,095  0,025  HIV-1 integrase (Strand Transfer) inhibitor
0,093  0,024  Beta tubulin antagonist
0,111  0,044  Estrogen receptor beta antagonist
0,195  0,128  Antiviral (West Nile virus)
0,173  0,106  Pneumotoxic
0,086  0,020  Beta 3 adrenoreceptor antagonist
0,070  0,005  Melatonin 1 agonist
0,072  0,008  Dopamine D5 agonist
0,219  0,155  Vasodilator, peripheral
0,081  0,019  Alpha tubulin antagonist
0,165  0,104  Psychostimulant
0,117  0,056  Falcipain 3 inhibitor
0,145  0,085  Chemopreventive
0,075  0,015  Topoisomerase II beta inhibitor
0,085  0,025  Endocannabinoid uptake inhibitor
0,107  0,048  UGT2B11 substrate
0,177  0,118  Antineoplastic (cervical cancer)
0,097  0,039  Granulocyte macrophage colony stimulating factor agonist
0,061  0,005  Melatonin 1 antagonist
0,122  0,066  Adenylate cyclase inhibitor
0,196  0,139  Chemoprotective
0,094  0,039  Sodium/hydrogen exchanger 5 inhibitor
0,097  0,042  Topoisomerase II alpha inhibitor
0,095  0,040  Vanilloid agonist
0,155  0,101  Toxic, respiratory center
0,105  0,051  Breast cancer-resistant protein inhibitor
0,087  0,033  HIV-1 integrase inhibitor
0,197  0,144  Prostate cancer treatment
0,114  0,062  SULT1A1 substrate
0,125  0,073  Antihyperlipoproteinemic
0,191  0,140  Analeptic
0,125  0,074  Retinoprotector
0,129  0,078  Antifungal enhancer
0,126  0,076  Interleukin 4 antagonist
0,086  0,038  SULT1A2 substrate
0,083  0,035  Dopamine agonist
0,212  0,164  Apoptosis antagonist
0,090  0,042  Alpha 2a adrenoreceptor antagonist
0,091  0,044  Adrenaline agonist
0,113  0,067  TRPA1 agonist
0,112  0,066  Aldehyde dehydrogenase substrate
0,063  0,016  Cathepsin L2 inhibitor
0,115  0,069  Cholesterol synthesis inhibitor
0,183  0,137  Superoxide dismutase inhibitor
0,106  0,062  Antiinfertility, female
0,189  0,146  Antineoplastic (sarcoma)
0,095  0,052  Alpha 2 adrenoreceptor antagonist
0,123  0,080  Antihemorrhagic
0,084  0,043  Keratolytic
0,045  0,004  Melatonin receptor 1A antagonist
0,150  0,110  Hepatoprotectant
0,136  0,096  UGT1A4 substrate
0,125  0,088  Lipid peroxidase inhibitor
0,128  0,093  SULT1A3 substrate
0,045  0,010  Melatonin receptor 1A agonist
0,105  0,071  Cystathionine beta-synthase inhibitor
0,058  0,025  Vanilloid 2 antagonist
0,093  0,060  Antiadrenergic
0,105  0,074  Antiviral (SARS coronavirus)
0,105  0,074  Antiviral (Coronavirus)
0,121  0,089  Antineoplastic (squamous cell carcinoma)
0,172  0,140  Age-related macular degeneration treatment
0,152  0,121  Abortion inducer
0,203  0,173  Antithrombotic
0,090  0,060  Adrenaline antagonist
0,060  0,030  Estrogen agonist
0,057  0,027  Beta 2 adrenoreceptor antagonist
0,144  0,116  Neurotensin receptor agonist
0,068  0,041  Dopamine D1 antagonist
0,166  0,139  VCAM1 expression inhibitor
0,152  0,126  Antihypertriglyceridemic
0,053  0,028  Factor III inhibitor
0,063  0,039  Beta 2 adrenoreceptor agonist
0,141  0,117  Aldehyde oxidase substrate
0,115  0,092  Toll-Like receptor antagonist
0,128  0,105  UGT2B9 substrate
0,096  0,073  Carbonic anhydrase XV inhibitor
0,069  0,048  Anticholelithogenic
0,099  0,077  Monophenol monooxygenase inhibitor
0,188  0,167  Gastrin inhibitor
0,049  0,029  Carbonic anhydrase VII inhibitor
0,056  0,037  Postmenopausal disorders treatment
0,068  0,050  SULT2A1 substrate
0,133  0,115  Carcinogenic, group 1
0,146  0,128  Phobic disorders treatment
0,057  0,039  Postcoital contraceptive
0,062  0,045  5 Hydroxytryptamine 2A agonist
0,027  0,011  Dopamine D1 agonist
0,037  0,022  Estrogen receptor alpha agonist
0,095  0,081  Choleretic
0,018  0,004  Melatonin 2 antagonist
0,083  0,070  Tocolytic
0,041  0,030  Estradiol 17 beta-dehydrogenase inhibitor
0,095  0,085  Mucolytic
0,095  0,085  Chelator
0,114  0,105  Antineoplastic (uterine cancer)
0,105  0,096  Cyclooxygenase 3 inhibitor
0,083  0,076  SULT1E1 substrate
0,209  0,203  15-Lipoxygenase inhibitor
0,139  0,134  P-glycoprotein inhibitor
0,151  0,146  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,018  0,013  Estrogen-related receptor gamma agonist
0,060  0,056  Uterine relaxant
0,060  0,057  Calcium channel P-type blocker
0,119  0,116  Sigma receptor agonist
0,040  0,038  Glycine transporter 2 inhibitor
0,056  0,056  Hyperparathyroidism treatment

